244 related articles for article (PubMed ID: 29512864)
21. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
[TBL] [Abstract][Full Text] [Related]
22. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
23. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
Huang JB; Xue HM; Chen YY; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
[TBL] [Abstract][Full Text] [Related]
25. Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?
Sedky MS; Rahman HA; Moussa E; Taha H; Raafat T; Hassanein O
Indian J Pediatr; 2016 Mar; 83(3):214-9. PubMed ID: 26133729
[TBL] [Abstract][Full Text] [Related]
26. Circulating cell-free BRAF
Héritier S; Hélias-Rodzewicz Z; Lapillonne H; Terrones N; Garrigou S; Normand C; Barkaoui MA; Miron J; Plat G; Aladjidi N; Pagnier A; Deville A; Gillibert-Yvert M; Moshous D; Lefèvre-Utile A; Lutun A; Paillard C; Thomas C; Jeziorski E; Nizard P; Taly V; Emile JF; Donadieu J
Br J Haematol; 2017 Aug; 178(3):457-467. PubMed ID: 28444728
[TBL] [Abstract][Full Text] [Related]
27. Treatment Outcome of Children With Multisystem Langerhans Cell Histiocytosis: The Experience of a Single Children's Hospital in Shanghai, China.
Gao YJ; Su M; Tang JY; Pan C; Chen J
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e9-e12. PubMed ID: 29200145
[TBL] [Abstract][Full Text] [Related]
28. Acute leukemia in association with Langerhans cell histiocytosis.
Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal lesion in adult-onset Langerhans cell histiocytosis.
Matsubara Y; Kobayashi M; Hijikata Y; Ota Y; Hirata Y; Lim LA; Yotsuyanagi H; Tojo A
Int J Clin Oncol; 2020 Nov; 25(11):1945-1950. PubMed ID: 32901339
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.
Gadner H; Grois N; Arico M; Broadbent V; Ceci A; Jakobson A; Komp D; Michaelis J; Nicholson S; Pötschger U; Pritchard J; Ladisch S;
J Pediatr; 2001 May; 138(5):728-34. PubMed ID: 11343051
[TBL] [Abstract][Full Text] [Related]
31. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine.
Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V
Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine A therapy for multisystem langerhans cell histiocytosis.
Minkov M; Grois N; Broadbent V; Ceci A; Jakobson A; Ladisch S
Med Pediatr Oncol; 1999 Nov; 33(5):482-5. PubMed ID: 10531573
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study.
Cui L; Wang CJ; Lian HY; Zhang L; Ma HH; Wang D; Chen FF; Zhang Q; Yang Y; Wei A; Huang XT; Zhu T; Wang TY; Li ZG; Zhang R
Am J Hematol; 2023 Apr; 98(4):598-607. PubMed ID: 36594188
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and treatment outcomes of Langerhans cell histiocytosis: a nationwide survey from Korea histiocytosis working party.
Kim BE; Koh KN; Suh JK; Im HJ; Song JS; Lee JW; Kang HJ; Park KD; Shin HY; Choi HS; Lee SH; Yoo KH; Sung KW; Koo HH; Jung HL; Chung NG; Cho B; Kim HK; Lyu CJ; Baek HJ; Kook H; Park JE; Park HJ; Park BK; Yoo ES; Ryu KH; Lee KS; Kim HS; Lee JM; Park ES; Yoon HS; Lee KC; Lee MJ; Lim YT; Kim HM; Park SK; Park JA; Kim SK; Park M; Lim YJ; Lee YH; Seo JJ;
J Pediatr Hematol Oncol; 2014 Mar; 36(2):125-33. PubMed ID: 24276037
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes and screening for organ involvement in pediatric Langerhans cell histiocytosis in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group.
Monsereenusorn C; Suwannaying K; Techavichit P; Sathitsamitphong L; Komvilaisak P; Rujkijyanont P; Seksarn P; Charoenkwan P; Pakakasama S
Int J Hematol; 2022 Apr; 115(4):563-574. PubMed ID: 35099760
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with Langerhans cell histiocytosis.
Rosso DA; Ripoli MF; Roy A; Diez RA; Zelazko ME; Braier JL
J Pediatr Hematol Oncol; 2003 Jun; 25(6):480-3. PubMed ID: 12794527
[TBL] [Abstract][Full Text] [Related]
37. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
[TBL] [Abstract][Full Text] [Related]
38. Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone.
Wang W; Ge J; Ma H; Lian H; Cui L; Zhao Y; Li Z; Wang T; Zhang R
BMC Pediatr; 2024 Jan; 24(1):1. PubMed ID: 38172736
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution.
Kamath S; Arkader A; Jubran RF
J Pediatr Orthop; 2014 Dec; 34(8):825-30. PubMed ID: 25387157
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Langerhans cell histiocytosis in children with etoposide.
Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T
Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
